Gallbladder cancer: Historical treatment and new management options

doi:10.4251/wjgo.v13.i10.1317

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11257)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

919

WORD

176

HTML

8340

Figures (1-5)

245

Tables (1-5)

298

Sum=9978

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

467

Download

812

Sum=1279

Oct 15, 2021 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1317-1335
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1317

Full Size Figure Download Figure

Figure 4 Molecular profiling of biliary tract cancers. Percentage of main targetable and non-targetable genetic alterations are summarized for intrahepatic cholangiocarcinoma (iCCA), extrahepatic cholangiocarcinoma (eCCA), and gallbladder cancer (GBC). Within targetable alterations, there are clear variations within the molecular profiling of these tumors with a predominance of IDH and FGFR alterations in iCCA and ERBB2/3 (HER2/3) in eCCA and GBC[71]. Citation: Lamarca A, Barriuso J, McNamara MG, Valle JW. Molecular targeted therapies: Ready for "prime time" in biliary tract cancer. J Hepatol 2020; 73(1): 170-185. Copyright ©2020 European Association for the study of the Liver. Published by Elsevier B.V[71]. CCA: Cholangiocarcinoma; eCCA: Extrahepatic cholangiocarcinoma; GBC: Gallbladder cancer; iCCA: Intrahepatic cholangiocarcinoma.

Citation: Okumura K, Gogna S, Gachabayov M, Felsenreich DM, McGuirk M, Rojas A, Quintero L, Seshadri R, Gu K, Dong XD. Gallbladder cancer: Historical treatment and new management options. World J Gastrointest Oncol 2021; 13(10): 1317-1335
URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1317.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1317